A comparison of COVID-19 incidence rates across six European countries in 2021

Author:

Padget Michael1,Adam Pauline1,Dorfmuller Marina1,Blondel Clara1,Campos-Matos Ines2,Fayad Myriam1,Mateo-Urdiales Alberto3,Mesher David4,Pistol Adriana56,Rebolledo Javiera7,Riccardo Flavia3,Riess Maximilian8,Rusu Lavinia Cipriana5,Che Didier1,Coignard Bruno1,

Affiliation:

1. Santé Publique France, Saint Maurice, France

2. COVID Vaccines and Epidemiology, UK Health Security Agency, United Kingdom

3. Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy

4. International COVID Team, UK Health Security Agency, United Kingdom

5. National Institute of Public Health Bucharest, Romania

6. University of Medicine “Carol Davila” Bucharest, Romania

7. Department of epidemiology and infectious diseases, Sciensano, Brussels, Belgium

8. Public Health Agency of Sweden, Stockholm, Sweden

Abstract

International comparisons of COVID-19 incidence rates have helped gain insights into the characteristics of the disease, benchmark disease impact, shape public health measures and inform potential travel restrictions and border control measures. However, these comparisons may be biased by differences in COVID-19 surveillance systems and approaches to reporting in each country. To better understand these differences and their impact on incidence comparisons, we collected data on surveillance systems from six European countries: Belgium, England, France, Italy, Romania and Sweden. Data collected included: target testing populations, access to testing, case definitions, data entry and management and statistical approaches to incidence calculation. Average testing, incidence and contextual data were also collected. Data represented the surveillance systems as they were in mid-May 2021. Overall, important differences between surveillance systems were detected. Results showed wide variations in testing rates, access to free testing and the types of tests recorded in national databases, which may substantially limit incidence comparability. By systematically including testing information when comparing incidence rates, these comparisons may be greatly improved. New indicators incorporating testing or existing indicators such as death or hospitalisation will be important to improving international comparisons.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

Reference19 articles.

1. Updated rapid risk assessment from ECDC on the outbreak of COVID-19: increased transmission globally.;Euro Surveill,2020

2. The Efficacy of Lockdown Against COVID-19: A Cross-Country Panel Analysis.;Alfano;Appl Health Econ Health Policy,2020

3. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.;Voigt;PLoS One,2022

4. Our World in Data. Where our work on the Coronavirus pandemic is used in media and research. [Accessed: 15 Mar 2022]. Available from: https://ourworldindata.org/covid-media-coverage

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3